Skip to content

Current ratio at other companies

Schrodinger logo
SchrodingerSDGR
2.7×-0.7×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
5.5×+1.4×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
+0.9×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
14.1×+3.9×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
7.6×-0.7×
ADMA Biologics logo
ADMA BiologicsADMA
+0.4×

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on the most recent quarter.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's current ratio?
Absci Corporation (ABSI) reported current ratio of 6.6× in Q1 2026.
How has Absci Corporation's current ratio changed year-over-year?
Absci Corporation's current ratio increased by 15.2% year-over-year, from 5.7× to 6.6×.
What is the long-term trend for Absci Corporation's current ratio?
Over 5 years (2020 to 2025), Absci Corporation's current ratio has grown at a -2.0% compound annual growth rate (CAGR), from 7.3× to 6.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.